Velcura Therapeutics™, Inc. is a leadingthe foremost biotechnology firm in the treatment of bone-related injuries and bone disorders. Velcura develops therapies directed at stimulating bone formation. Velcura can grow human bone outside the body (ex vivo) using a rapid (7 – 10 days) and reliable method. We apply molecular and biological bone assays to the systematic discovery of the genes, biological pathways, and drug candidates that accelerate bone formation. From this, we discover new therapies for bone disorders such as Osteoporosis, Bone Cancer, Bone Fractures, and other diseases of bone.